Our Resources | Association for Accessible Medicines

New Blog - Inflation Rebate Proposal Builds on Bad Policy for Generics

Vial and syringe injection

Dec 3, 2021 | Craig Burton

The Evidence Is Clear: Biosimilar Competition Will Achieve More Savings for Patients Than Build Back Better’s Negotiations

Dec 2, 2021 | Monét Stanford

How Inflation Penalties for Generic Medicines Could Worsen Drug Shortages

2021 U.S. Generic and Biosimilar Medicines Savings Report

Nov 30, 2021 | Erica Klinger

GRx+Biosims 2021 | Generics + Biosimilars Conference

Nov 29, 2021 | Erica Klinger

Process & Progress: A Recap of GRx+Biosims 2021

AAM All Access Podcast

Nov 20, 2021 | Dan Leonard

AAM All Access Podcast: Lachman Consultants’ Robert Pollock

Doesn't Add Up patient photo

Nov 19, 2021 | Rachel Schwartz

Association for Accessible Medicines Warns Build Back Better Act Threatens Patient Access

Female pharmacist services senior female customer buying prescription medicine package and paying using contactless method

Nov 15, 2021 | Craig Burton

Inflation Rebate Proposal Builds on Bad Policy for Generics

Dr. Robert Califf

Nov 12, 2021 | Rachel Schwartz

AAM Statement on the Nomination of Dr. Robert Califf to Lead FDA

HHS Proposal Will Help America’s Patients Realize the Full Value of Their Generics and Biosimilars

Nov 12, 2021 | Monét Stanford

Medicare Negotiations Serve as a Catalyst to a Perpetual Monopoly

Nov 10, 2021 | Rachel Schwartz

Paula Witt Joins AAM as Senior Manager, State Government Affairs

Misguided Drug Pricing Reform

Nov 2, 2021 | Rachel Schwartz

AAM Opposes Latest Prescription Drug Reform Framework

Cover of A Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain

Nov 2, 2021 | Jonathan Kimball

Second Edition of AAM’s Blueprint to Enhance the Security of the U.S. Pharmaceutical Supply Chain